My Cart

Siglec-10

Siglec-10 Overview

English NameSialic acid-binding Ig-like lectin 10Approved Drugs0
Drugs in Clinical Trials3Target SynonymUNQ477/PRO940,SIGLEC10,Sialic Acid Binding Ig Like Lectin 10,Sialic Acid Binding Ig-Like Lectin 10 Ig-Like Lectin 7,Siglec-Like Protein 2,Siglec-Like Gene 2,SLG2,Sialic Acid-Binding Ig-Like Lectin 10,Sialic Acid Binding Ig-Like Lectin 10,Siglec-10,PRO940,MGC126774
Highest Development StagePhase 3 Clinical
English NameSialic acid-binding Ig-like lectin 10
Target SynonymUNQ477/PRO940,SIGLEC10,Sialic Acid Binding Ig Like Lectin 10,Sialic Acid Binding Ig-Like Lectin 10 Ig-Like Lectin 7,Siglec-Like Protein 2,Siglec-Like Gene 2,SLG2,Sialic Acid-Binding Ig-Like Lectin 10,Sialic Acid Binding Ig-Like Lectin 10,Siglec-10,PRO940,MGC126774
Approved Drugs0
Drugs in Clinical Trials3
Highest Development StagePhase 3 Clinical

Siglec-10 Background

The siglecs (sialic acid-binding Ig-like lectins) are a distinct subset of the Ig superfamily with adhesion-molecule-like structure. We describe here a novel member of the siglec protein family that shares a similar structure including five Ig-like domains, a transmembrane domain, and a cytoplasmic tail containing two ITIM-signaling motifs. Siglec-10 was identified through database mining of an asthmatic eosinophil EST library. The Siglec-10-VAP-1 interaction seems to mediate lymphocyte adhesion to endothelium and has the potential to modify the inflammatory microenvironment via the enzymatic end products.

Siglec-10 Synonyms

SIGLEC10,MGC126774,PRO940,Siglec10,SLG2

Clinical Drug Information

English NameResearch CodeHighest Development StageCompanyIndicationClinical Trial
Efprezimod alfaCD24-Fc; HAS-CD24; CD24-Fc-IgG; MK-7110; MK7110Phase 3 ClinicalOncoimmune IncCoronavirus Disease 2019 (COVID-19); Dyslipidemias; Graft vs Host Disease; Hematopoietic stem cell transplantation (HSCT); HIV Infections; Leukemia; Leukemia, Myeloid, Acute; Melanoma; Myelodysplastic Syndromes; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Solid tumours
Details
EXO-CD24Phase 2 ClinicalNano24med, Tel-Aviv Sourasky Medical CenterCoronavirus Disease 2019 (COVID-19); Respiratory Distress Syndrome, Adult
Details
ONC-841ONC-841Phase 1 ClinicalAcroImmune GroupAlzheimer Disease; Neoplasms; Solid tumours
Details

Product Reviews

  • V***w2023-03-17
    0People Like
    The timely fashion that this protein was delivered has helped us greatly. Knowing how reliable and effective Acro Biosystems is with their product delivery is refreshing. Having access to a quick vendor has helped push along studies. The user interface and accessibility of Acro’s website makes it easy to find exactly what we need when we need it. Definitely will continue to purchase from Acro.
  • A***r2022-10-20
    0People Like
    We have been using this Human Siglec-10 Protein, His Tag as a capture for an electrochemiluminescent immunoassay. The performance of the assay was very consistent; the background was low and signal-to-noise ratio was very good, so we were able to get great sensitivity. We’ve ordered from ACRO Biosystems several times for this assay and every time shipments are very consistent and timely, and the reagent is always in stock. They are also very responsive whenever we have product questions or documentation questions regarding certain lots.
  • C***e2022-09-23
    0People Like
    Service with Acro and their customer support is as quick as they are helpful. Product was needed as soon as possible for a study and they helped us out in getting the product shipped out and delivered us within 2 days of purchasing. Customer support personal are as friendly as they are insightful. Never have they disappointed when purchasing any of their products.
  • Overview
  • Product List
  • Product Reviews
  • Clinical Drug Information
Contact Us

[North America]: +1 800-810-0816
[Switzerland]: +41 800 040 012
[Asia & Pacific]: +86 400-682-2521

[North America]: 1 Innovation Way, Newark, DE 19711, USA
[Switzerland]: ACRObiosystems AG, c/o Zug Dammstrasse Centre AG, Dammstrasse 19, 6300 Zug Switzerland